Literature DB >> 9227160

Is there a future for extracorporeal photochemotherapy in the treatment of the rheumatological diseases?

M R Holbrook1, R J Powell.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9227160      PMCID： PMC1752399          DOI： 10.1136/ard.56.6.339

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  16 in total

1.  Clinical and experimental studies with 8-methoxypsoralen in vitiligo.

Authors:  A B LERNER; C R DENTON; T B FITZPATRICK
Journal:  J Invest Dermatol       Date:  1953-04       Impact factor: 8.551

2.  Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation.

Authors:  A Tyndall; C Black; J Finke; J Winkler; R Mertlesmann; H H Peter; A Gratwohl
Journal:  Lancet       Date:  1997-01-25       Impact factor: 79.321

3.  Photoinactivation of enzymes by linear and angular furocoumarins.

Authors:  F M Veronese; O Schiavon; R Bevilacqua; F Bordin; G Rodighiero
Journal:  Photochem Photobiol       Date:  1982-07       Impact factor: 3.421

4.  Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.

Authors:  A H Rook; B Freundlich; B V Jegasothy; M I Perez; W G Barr; S A Jimenez; R L Rietschel; B Wintroub; M B Kahaleh; J Varga
Journal:  Arch Dermatol       Date:  1992-03

5.  Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group.

Authors:  G V Campion; M E Lebsack; J Lookabaugh; G Gordon; M Catalano
Journal:  Arthritis Rheum       Date:  1996-07

6.  Treatment of psoriatic arthritis with extracorporeal photochemotherapy and conventional psoralen-ultraviolet A irradiation.

Authors:  C Vahlquist; M Larsson; J Ernerudh; G Berlin; T Skogh; A Vahlquist
Journal:  Arthritis Rheum       Date:  1996-09

7.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results.

Authors:  R Edelson; C Berger; F Gasparro; B Jegasothy; P Heald; B Wintroub; E Vonderheid; R Knobler; K Wolff; G Plewig
Journal:  N Engl J Med       Date:  1987-02-05       Impact factor: 91.245

8.  Interleukin-2 diphtheria fusion protein (DAB486IL-2) in refractory rheumatoid arthritis. A double-blind, placebo-controlled trial with open-label extension.

Authors:  L W Moreland; K L Sewell; D E Trentham; R P Bucy; W F Sullivan; R E Schrohenloher; R H Shmerling; K C Parker; W G Swartz; T G Woodworth
Journal:  Arthritis Rheum       Date:  1995-09

9.  Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1.

Authors:  A F Kavanaugh; L S Davis; L A Nichols; S H Norris; R Rothlein; L A Scharschmidt; P E Lipsky
Journal:  Arthritis Rheum       Date:  1994-07

10.  Effects of oral administration of type II collagen on rheumatoid arthritis.

Authors:  D E Trentham; R A Dynesius-Trentham; E J Orav; D Combitchi; C Lorenzo; K L Sewell; D A Hafler; H L Weiner
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.